Retrospective review of the use of high dose cyclophosphamide, bortezomib, doxorubicin, and dexamethasone (mCBAD) for the treatment of multiple myeloma and plasma cell leukemia
Retrospective review of the use of high dose cyclophosphamide, bortezomib, doxorubicin, and dexamethasone (mCBAD) for the treatment of multiple myeloma and plasma cell leukemia
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started